4/A//SEC Filing
Globeways Holdings Ltd 4/A
Accession 0001104659-15-003339
CIK 0001428522other
Filed
Jan 19, 7:00 PM ET
Accepted
Jan 20, 4:16 PM ET
Size
19.6 KB
Accession
0001104659-15-003339
Insider Transaction Report
Form 4/AAmended
F2 Bioscience IV L.P.
10% Owner
Transactions
- Other
Common Stock Warrant
2015-01-16−249,932→ 0 totalExercise: $14.00From: 2014-02-14Exp: 2019-02-14→ Common Stock (249,932 underlying) - Other
Common Stock Warrant
2015-01-16−121,396→ 0 total(indirect: By Fund)Exercise: $14.00From: 2014-02-14Exp: 2019-02-14→ Common Stock (121,396 underlying)
F2 Bioscience IV GP Ltd.
10% Owner
Transactions
- Other
Common Stock Warrant
2015-01-16−249,932→ 0 totalExercise: $14.00From: 2014-02-14Exp: 2019-02-14→ Common Stock (249,932 underlying) - Other
Common Stock Warrant
2015-01-16−121,396→ 0 total(indirect: By Fund)Exercise: $14.00From: 2014-02-14Exp: 2019-02-14→ Common Stock (121,396 underlying)
F2 Capital Ltd
10% Owner
Transactions
- Other
Common Stock Warrant
2015-01-16−121,396→ 0 total(indirect: By Fund)Exercise: $14.00From: 2014-02-14Exp: 2019-02-14→ Common Stock (121,396 underlying) - Other
Common Stock Warrant
2015-01-16−249,932→ 0 totalExercise: $14.00From: 2014-02-14Exp: 2019-02-14→ Common Stock (249,932 underlying)
Globeways Holdings Ltd
10% Owner
Transactions
- Other
Common Stock Warrant
2015-01-16−121,396→ 0 total(indirect: By Fund)Exercise: $14.00From: 2014-02-14Exp: 2019-02-14→ Common Stock (121,396 underlying) - Other
Common Stock Warrant
2015-01-16−249,932→ 0 totalExercise: $14.00From: 2014-02-14Exp: 2019-02-14→ Common Stock (249,932 underlying)
Priestley Katherine
10% Owner
Transactions
- Other
Common Stock Warrant
2015-01-16−249,932→ 0 totalExercise: $14.00From: 2014-02-14Exp: 2019-02-14→ Common Stock (249,932 underlying) - Other
Common Stock Warrant
2015-01-16−121,396→ 0 total(indirect: By Fund)Exercise: $14.00From: 2014-02-14Exp: 2019-02-14→ Common Stock (121,396 underlying)
F2 Bio Ventures V L.P.
10% Owner
Transactions
- Other
Common Stock Warrant
2015-01-16−249,932→ 0 totalExercise: $14.00From: 2014-02-14Exp: 2019-02-14→ Common Stock (249,932 underlying) - Other
Common Stock Warrant
2015-01-16−121,396→ 0 total(indirect: By Fund)Exercise: $14.00From: 2014-02-14Exp: 2019-02-14→ Common Stock (121,396 underlying)
F2 Bio Ventures GP Ltd.
10% Owner
Transactions
- Other
Common Stock Warrant
2015-01-16−249,932→ 0 totalExercise: $14.00From: 2014-02-14Exp: 2019-02-14→ Common Stock (249,932 underlying) - Other
Common Stock Warrant
2015-01-16−121,396→ 0 total(indirect: By Fund)Exercise: $14.00From: 2014-02-14Exp: 2019-02-14→ Common Stock (121,396 underlying)
Footnotes (5)
- [F1]The Form 4 filed on January 16, 2015 incorrectly stated the exercise price of the Common Stock Warrant as $2.694. This amendment is being filed to correct the exercise price.
- [F2]Reflects a liquidating pro rata distribution by F2 Bioscience IV L.P. ("F2 IV") to its limited and general partners.
- [F3]The reported securities are owned directly by F2 IV. F2 Bioscience IV GP Ltd. ("F2 IV GP") is the General Partner of F2 IV. Katherine Priestley and Globeways Holdings Limited ("Globeways") are members of F2 IV GP. F2 Capital Limited ("F2 Capital") is an investment adviser to F2 IV. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- [F4]Reflects a liquidating pro rata distribution by F2 Bio Ventures V L.P. ("F2 Bio") to its limited and general partners.
- [F5]The reported securities are owned directly by F2 Bio. F2 Bio Ventures GP Ltd. is the General Partner of F2 Bio. Globeways is the sole member of F2 Bio Ventures GP Ltd. F2 Capital is an investment adviser to F2 Bio. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
Documents
Issuer
Radius Health, Inc.
CIK 0001428522
Entity typeother
IncorporatedVirgin Islands, British
Related Parties
1- filerCIK 0001600769
Filing Metadata
- Form type
- 4/A
- Filed
- Jan 19, 7:00 PM ET
- Accepted
- Jan 20, 4:16 PM ET
- Size
- 19.6 KB